July 22, 2010
Axxiem Web Solutions is proud to announce the launch of
Vanthys - Vanthys Pharmaceutical Development (P) Ltd is a 50:50 joint venture of Eli Lilly and Company (USA) and Jubilant Organosys (India).
Vanthys is modeled after Lilly's early-stage development division, Chorus (www.choruspharma.com), which provides fast and efficient drug development exclusively through the utilization of external contract companies.
May 18, 2010
Axxiem Web Solutions is proud to announce the launch of
Lenoble Lumber - a leading supplier for entertainment sets, musuems, and residential moldings!
LeNoble Lumber specializes in selling a variety of lumber-based products to movies and tv shows. They sell everything from Molding and Trim to Prop Rocks and break-away Glass. Anything that Hollywood needs can be delivered by LeNoble Lumber.
February 17, 2010
Jim Haughwout, a Managing Partner at
Oulixeus Ltd., recently published an article on his Blog about the potential role of the Internet in Health Care.
Currently, medical professionals need to administrate large databases in order to keep track of their patients. They need to micromanage the database intensely, and there is rarely any means of the patients providing any input. The result is a sluggish system with slow reaction time. In the age of Facebook, where one's status can be posted to the world in a matter of seconds, having to wait days or weeks for important information about Clinical Trials is unacceptable.
Read the rest of this story on
Jim's Blog.
Axxiem Web Solutions is currently developing the solution to this program: Axxiem Clinical Trials. This system will allow feedback from all users, and will send instant notifications via multiple media in the event of a medical emergency. The days of Clinical Trial oversight will soon be gone, and the days of Axxiem Clinical Trials are coming soon.
January 7, 2010
Axxiem Web Solutions is proud to announce the launch of three Bio sites, EnzymeRx
www.enzymerx.com, Cytogel
www.cytogelpharma.com, and NContact
www.ncontactsurgical.com.
The goal for the new website for EnzymeRx
www.enzymerx.com, was to emphasize their innovative technological approach in changing the treatment paradigm for refractory gout with a custom medical illustration; speak to multiple audiences, including Venture Capitalists,
Physicians, Patients, and Pharma Companies alike; and provide pertinent information about enrolling in patient trials. Tony Fiorino, President and CEO, had this to say:
"We are thrilled with our new website built by Axxiem. The success of this total redesign cannot be judged solely on the fantastic outcome, however - as important was the Axxiem process, including easy web-based conferences to review design elements, a knowledge of healthcare that led to very helpful suggestions in tailoring content, and great responsiveness and attention to detail in building a graphical depiction of our lead drug's mechanism of action. I should also add that they exhibited great patience throughout the process, as our business activities sometimes limited how much time we had available to devote to the website redesign."
Background Pattern
Cytogel
www.cytogelpharma.com, came to us needing extensive redesign of their site, in part to improve user experience, but primarily to showcase the company's novel hydrogel platform technology and analgesic products and to speak to pharmaceutical companies and investor audiences, encouraging new business opportunities for Cytogel.
Axxiem designed a site structure to allow for easy cross-referencing between Cytogel's technologies and target markets. A page was also dedicated to partnership opportunities to encourage potential partners or investors to contact Cytogel. The custom logo and re-designed charts all stay consistent with the look and feel of the entire site, providing a strong sense of brand identity.
